SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

31 Jul 2012 15:42

RNS Number : 9612I
Caledonia Investments PLC
31 July 2012
 



NOTIFICATION OF TRANSACTION OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBIILTY AND CONNECTED PERSONS

 

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

 

(i) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

 

(ii) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

 

(iii) An issuer making a notification in respect of options granted to a director / person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

 

(iv) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

 

1

Name of the issuer:

 

 

CALEDONIA INVESTMENTS PLC

2

The notification relates to a transaction notified in accordance with:

 

DR 3.1.4R(1)(a).

 

3

Name of person discharging managerial responsibilities / director:

 

 

 

R B WOODS

4

State whether the notification relates to a person connected with a person discharging managerial responsibilities /director named in 3 and identify the connected person:

 

N/A

 

5

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest:

 

BENEFICIAL HOLDING OF PERSON NAMED IN 3

 

6

Description of shares, debentures, derivatives or financial instruments relating to shares:

 

 

 

ORDINARY 5P SHARES

7

Name of registered shareholder and, if more than one, the number of shares held by each of them:

 

ROBERT AND GEORGIANA WOODS

 

8

State the nature of the transaction:

 

 

 

PURCHASE OF SHARES

 

9

Number of shares acquired.

 

 

2,000

 

10

Percentage of issued class acquired (excluding treasury shares)

 

0.004%

 

11

Number of shares disposed:

 

NONE

12

Percentage of issued class disposed

 

NONE

 

 

13

Price per share or value of transaction

 

£14.24 PER SHARE

 

 

 

 

 

14

Date and place of transaction

 

31 JULY 2012, LONDON

15

Total holding and total percentage holding (excluding treasury shares)

 

Beneficial - 2,000 shares (0.004%)

 

16

Date issuer informed of transaction

 

 

31 JULY 2012

17

Date of grant

 

 

N/A

18

Period during which or date on which it can be exercised

 

N/A

 

19

Total amount paid (if any) for grant of the option

 

N/A

 

20

Description of shares or debentures involved

 

N/A

21

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

 

N/A

22

Total number of shares or debentures over which options held following notification

 

N/A

 

 

23

Any additional information

 

NONE

24

Name of contact and telephone number for queries

 

G P DENISON

+44 20 7802 8080

 

Name and signature of duly authorised officer of issuer responsible for making notification

 

G P DENISON

COMPANY SECRETARY

 

Date of notification

 

31 JULY 2012

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSDFFLFFESELW
Date   Source Headline
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 202411:29 amRNSNet Asset Value(s)
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20244:00 pmRNSAnnual Financial Report
7th Jun 20245:22 pmRNSDirector/PDMR Shareholding
6th Jun 20243:28 pmRNSDirector/PDMR Shareholding
6th Jun 20249:39 amRNSNet Asset Value(s)
30th May 20242:55 pmRNSDirector/PDMR Shareholding
21st May 20247:00 amRNSFinal Results
7th May 202410:40 amRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.